scholarly journals Surgeon–anaesthesiologist team case volume and perioperative outcomes in total joint arthroplasty

2020 ◽  
Vol 125 (5) ◽  
pp. e395-e396
Author(s):  
Stavros G. Memtsoudis ◽  
Lauren A. Wilson ◽  
Jiabin Liu ◽  
Jashvant Poeran
2009 ◽  
Vol 91 (7) ◽  
pp. 1621-1629 ◽  
Author(s):  
Milford H Marchant ◽  
Nicholas A Viens ◽  
Chad Cook ◽  
Thomas Parker Vail ◽  
Michael P Bolognesi

2020 ◽  
Vol 35 (6) ◽  
pp. 1516-1520
Author(s):  
Jesus M. Villa ◽  
Tejbir S. Pannu ◽  
Carlos A. Higuera ◽  
Juan C. Suarez ◽  
Preetesh D. Patel ◽  
...  

2019 ◽  
Vol 123 (5) ◽  
pp. 679-687
Author(s):  
Stavros G. Memtsoudis ◽  
Lauren A. Wilson ◽  
Janis Bekeris ◽  
Jiabin Liu ◽  
Lazaros Poultsides ◽  
...  

2021 ◽  
Vol 11 ◽  
pp. 6-9
Author(s):  
Carl L. Herndon ◽  
Matthew M. Levitsky ◽  
Chimere Ezuma ◽  
Nana O. Sarpong ◽  
Roshan P. Shah ◽  
...  

Arthroplasty ◽  
2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Chelsea Matzko ◽  
Zachary P. Berliner ◽  
Gregg Husk ◽  
Bushra Mina ◽  
Barton Nisonson ◽  
...  

Abstract Background Guidelines support aspirin thromboprophylaxis for primary total hip and knee arthroplasty (THA and TKA) but supporting evidence has come from high volume centers and the practice remains controversial. Methods We studied 4562 Medicare patients who underwent elective primary THA (1736, 38.1%) or TKA (2826, 61.9%) at 9 diverse hospitals. Thirty-day claims data were combined with data from the health system’s electronic medical records to compare rates of venous thromboembolism (VTE) between patients who received prophylaxis with: (1) aspirin alone (47.3%), (2) a single, potent anticoagulant (29%), (3) antiplatelet agents other than aspirin or multiple anticoagulants (21.5%), or (4) low-dose subcutaneous unfractionated heparin or no anticoagulation (2.2%). Sub-analyses separately evaluating THA, TKA and cases from lower volume hospitals (n = 975) were performed. Results The 30-day VTE incidence was 0.6% (29/4562). VTE rates were equal in patients receiving aspirin and those receiving a single potent anticoagulant (0.5% in both groups). Patients with VTE were significantly older than patients without VTE (mean 76.5 vs. 73.1 years, P = 0.04). VTE rate did not associate with sex or hospital case volume. On bivariate analysis considering age, aspirin did not associate with greater VTE risk compared to a single potent anticoagulant (OR = 2.1, CI = 0.7–6.3) with the numbers available. Odds of VTE were increased with use of subcutaneous heparin or no anticoagulant (OR = 6.4, CI = 1.2–35.6) and with multiple anticoagulants (OR = 3.6, CI = 1.1–11.2). THA and TKA demonstrated similar rates of VTE (0.5% vs. 0.7%, respectively, P = 0.43). Of 975 cases done at lower volume hospitals, 387 received aspirin, none of whom developed VTE. Conclusions This study provides further support for aspirin as an effective form of pharmacological VTE prophylaxis after total joint arthroplasty in the setting of a multi-modal regimen using 30-day outcomes. VTE occurred in 0.7% of primary joint arthroplasties. Aspirin prophylaxis did not associate with greater VTE risk compared to potent anticoagulants in the total population or at lower volume hospitals.


Arthroplasty ◽  
2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Harold G. Moore ◽  
Marissa A. Justen ◽  
David S. Kirwin ◽  
Patrick J. Burroughs ◽  
Lee E. Rubin ◽  
...  

Abstract Background Prior studies have suggested that preoperative dehydration increases odds of perioperative complications in several areas of orthopedic surgery. This study aimed to evaluate whether preoperative hydration status is associated with the incidence of short-term complications after primary total joint arthroplasty. Methods The 2012–2019 National Surgical Quality Improvement Program (NSQIP) database was used to explore the relationship between preoperative dehydration (ratio of preoperative BUN divided by preoperative Creatinine (BUN/Creatinine) > 20) and perioperative outcomes of total hip (THA) and total knee arthroplasty (TKA) patients. Univariate comparisons and multivariate regression analyses were conducted to identify specific complications that occurred more often in patients with preoperative dehydration. Results Of 188,629 THA and 332,485 TKA patients, 46.3 and 47.0% had preoperative dehydration, respectively. After controlling for demographics and comorbidities, dehydrated THA patients were no more likely to experience a complication compared to their non-dehydrated counterparts (relative risk [RR] = 0.97, 99.7% Confidence Interval [CI]: 0.92–1.03, P = 0.138) nor increased risk of blood transfusion (RR = 1.02, CI = 0.96–1.08, P = 0.408). Similar to THA patients, dehydrated TKA patients were not more likely to have a complication after surgery (RR = 0.97, CI = 0.92–1.03, P = 0.138) and were at no greater risk of transfusion (RR = 1.02, CI = 0.96–1.07, P = 0.408). A sub-analysis covering only patients with BUN and Cr values determined within 24 h after surgery was performed and similarly found no significant increase in perioperative complications or transfusion. Conclusion Overall, preoperative dehydration in patients undergoing THA/TKA did not appear to increase risk of transfusion or other perioperative complications. Further research is needed to characterize the role of hydration prior to elective total joint arthroplasty.


Sign in / Sign up

Export Citation Format

Share Document